LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.22
-0.02 (-0.28%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.

The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder.

In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers.

LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

LifeStance Health Group, Inc.
LifeStance Health Group logo
Country United States
Founded 2015
IPO Date Jun 10, 2021
Industry Medical Care Facilities
Sector Healthcare
Employees 9,325
CEO Kenneth Burdick

Contact Details

Address:
4800 North Scottsdale Road, Suite 2300
Scottsdale, Arizona 85251
United States
Phone 602 767 2100
Website lifestance.com

Stock Details

Ticker Symbol LFST
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $18.00
CIK Code 0001845257
CUSIP Number 53228F101
ISIN Number US53228F1012
SIC Code 8000

Key Executives

Name Position
Kenneth Alan Burdick Chief Executive Officer and Chairman
David Patrick Bourdon Chief Financial Officer and Treasurer
Pablo Pantaleoni Chief Digital Officer
Monica Prokocki Vice President of Investor Relations
Brooke Matthews Director of Public Relations
Ann Varanakis Chief People Officer
Dr. Ujjwal Ramtekkar CPE, M.B.A., M.D. Chief Medical Officer
Richard Hall Executive Vice President of Shared Services
Lisa Keise Miller Executive Vice President of Practice Operations
Toi Valentine Senior Vice President and Chief Strategy Officer

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 144 Filing
Nov 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 7, 2024 10-Q Quarterly Report
Nov 7, 2024 8-K Current Report
Sep 13, 2024 144 Filing
Sep 6, 2024 144/A Filing
Aug 21, 2024 144 Filing
Aug 20, 2024 144 Filing